“The time has come to make sure that the potency and active ingredient profile of cannabis available in the consumer marketplace is known, and transparent"
Oakland, California (PRWEB) October 08, 2014
Today, Steep Hill Labs, Inc. announced the release of its highly anticipated, next generation cannabis testing technology, the QuantaCann2. “We are excited that the QuantaCann2 is now available for lease in all states where legal cannabis markets exist,” said CEO and Co-Founder David Lampach. “Our advanced optical platform and cloud-based analytics can deliver laboratory-grade THC, CBD and moisture test results anywhere in the world in under 60 seconds.”
QuantaCann2 is the world’s first remote, on-site instant potency and process analysis technology that enables business users such as cannabis producers, processors, dispensaries, other testing labs and even regulators to have real-time access to chemical information for their raw materials and products at their own locations. The platform aggregates information from Steep Hill’s world-leading database of test results and other proprietary resources, using a sophisticated, proprietary SaaS interface and analytical models. The QuantaCann2 scans the source material using near-infrared spectrometry and sends the spectral scans through the cloud for analytical processing. Results are delivered through the QC2’s unique user interface, providing instant, conclusive potency and moisture data to users, dynamically and virtually.
“The time has come to make sure that the potency and active ingredient profile of cannabis available in the consumer marketplace is known, and transparent. By democratizing access to sophisticated potency testing, the QuantaCann2 is an important tool for the cannabis industry in the effort to maximize product safety and consumer knowledge,” emphasized Lampach in making the announcement.
QuantaCann2’s testing functions, processes, and a modified version of its user interface were featured in Sunday night’s episode of CBS’s CSI: Crime Scene Investigation, entitled "Buzz Kill.”
“We are pleased that CSI chose our QuantaCann2 technology to help solve the crime in ’Buzz Kill.’ As the nation’s leading provider of cannabis testing, analytics and quality management solutions for the burgeoning industry, the acknowledgement and validation that comes from such prominent media recognition is an honor,” said Lampach. “Identifying unique strains of cannabis and matching them to a large database is not only possible in helping to solve a crime on television, it is actually already possible in real life today through Steep Hill’s technological innovations such as the QuantaCann2.”
For more information on how to lease a QuantaCann2, please visit http://steephilllab.com/quantacann/ or call 510-562-7400 to speak with a Steep Hill representative.
ABOUT STEEP HILL LABS, INC.
Founded in Oakland, CA, in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics in the United States, and internationally. Steep Hill pioneered the first medical cannabis potency and microbiological contaminants testing methodology used in California, which was the first state to legalize medical cannabis. The company has since developed a variety of revolutionary cannabis industry testing products, including the QuantaCann, and now the QuantaCann2. Steep Hill has also provided expert consulting advice to many U.S. states and local municipalities on effective cannabis testing, quality assurance and regulation for a healthy and safe supply of medical cannabis. For more information please visit http://steephilllab.com/.